Masimo to Report Third Quarter 2017 Financial Results after Market Close on Tuesday, October 31
October 17 2017 - 09:00AM
Business Wire
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m.
ET)
Masimo (NASDAQ: MASI) announced today that it will release
financial results for the third quarter ended September 30, 2017,
after the market closes on Tuesday, October 31, 2017. The
conference call to review the results will begin at 1:30 p.m. PT
(4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief
Executive Officer, and Micah Young, Executive Vice President and
Chief Financial Officer, along with Mark de Raad, the company’s
retiring CFO.
A live webcast of the conference call will be available online
from the investor relations page of the company's corporate website
at www.masimo.com. The dial-in numbers are (888) 520-7182 for
domestic callers and +1 (706) 758-3929 for international callers.
The reservation code for both dial-in numbers is 1906046. After the
live webcast, the call will be available on Masimo's website
through November 28, 2017. In addition, a telephonic replay of the
call will be available through November 14, 2017. The replay
dial-in numbers are (855) 859-2056 for domestic callers and +1
(404) 537-3406 for international callers. Please use reservation
code 1906046.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative
noninvasive monitoring technologies. Our mission is to improve
patient outcomes and reduce the cost of care by taking noninvasive
monitoring to new sites and applications. In 1995, the company
debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse
oximetry, which has been shown in multiple studies to significantly
reduce false alarms and accurately monitor for true alarms. Masimo
SET® is estimated to be used on more than 100 million patients in
leading hospitals and other healthcare settings around the world.
In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology,
allowing noninvasive and continuous monitoring of blood
constituents that previously could only be measured invasively,
including total hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and more
recently, Pleth Variability Index (PVI®) and Oxygen Reserve Index
(ORI™), in addition to SpO2, pulse rate, and perfusion index (PI).
In 2014, Masimo introduced Root®, an intuitive patient monitoring
and connectivity platform with the Masimo Open Connect (MOC-9™)
interface. Masimo is also taking an active leadership role in
mHealth with products such as the Radius-7™ wearable patient
monitor and the MightySat™ fingertip pulse oximeter. Additional
information about Masimo and its products may be found at
www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient
Outcome and Reducing Cost of Care by Taking Noninvasive Monitoring
to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet,
PVI are trademarks or registered trademarks of Masimo.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171017005585/en/
MasimoInvestor Contact:Eli Kammerman, (949)
297-7077ekammerman@masimo.comorMedia Contact:Irene Paigah,
(858) 859-7001irenep@masimo.com
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Masimo (NASDAQ:MASI)
Historical Stock Chart
From Mar 2023 to Mar 2024